Geode Capital Management LLC Acquires 5,771 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Geode Capital Management LLC grew its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 4.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 124,761 shares of the medical instruments supplier’s stock after acquiring an additional 5,771 shares during the quarter. Geode Capital Management LLC owned about 2.30% of Mesa Laboratories worth $16,205,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Canada Pension Plan Investment Board acquired a new stake in shares of Mesa Laboratories in the 2nd quarter valued at $26,000. FMR LLC grew its stake in shares of Mesa Laboratories by 34.1% during the third quarter. FMR LLC now owns 393 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 100 shares during the last quarter. Quantbot Technologies LP bought a new position in Mesa Laboratories in the third quarter valued at about $70,000. Sanctuary Advisors LLC bought a new stake in Mesa Laboratories during the 2nd quarter worth approximately $183,000. Finally, Berry Wealth Group LP bought a new position in shares of Mesa Laboratories during the third quarter valued at $204,000. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Mesa Laboratories Stock Performance

Shares of MLAB stock opened at $133.06 on Monday. The company has a quick ratio of 0.51, a current ratio of 0.70 and a debt-to-equity ratio of 0.65. Mesa Laboratories, Inc. has a 52 week low of $83.68 and a 52 week high of $141.17. The firm has a 50 day moving average of $120.56 and a 200-day moving average of $117.45. The company has a market cap of $722.65 million, a price-to-earnings ratio of -2.92 and a beta of 0.86.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 29th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.48%. Mesa Laboratories’s dividend payout ratio (DPR) is presently -1.40%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on MLAB shares. StockNews.com lowered Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Evercore ISI boosted their price target on shares of Mesa Laboratories from $120.00 to $160.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st.

Insider Activity

In related news, CEO Gary M. Owens sold 2,518 shares of the company’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $113.62, for a total value of $286,095.16. Following the sale, the chief executive officer now owns 45,888 shares in the company, valued at $5,213,794.56. This represents a 5.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 4.40% of the stock is currently owned by company insiders.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.